Wasp venom immunotherapy induces a shift from IL-4-producing towards interferon-gamma-producing CD4+ and CD8+ T lymphocytes. (Q43650600)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11422133%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

title

Wasp venom immunotherapy induces a shift from IL-4-producing towards interferon-gamma-producing CD4+ and CD8+ T lymphocytes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11422133%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11422133%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

author name string

A J Schuerwegh

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11422133%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

L S De Clerck

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11422133%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

W J Stevens

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11422133%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

language of work or name

1 reference

1 May 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11422133%20AND%20SRC:MED&resulttype=core&format=json

Clinical & Experimental Allergy

8 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11422133%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11422133%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11422133%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

740-746

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11422133%20AND%20SRC:MED&resulttype=core&format=json

Stinging insect allergy: natural history and modification with venom immunotherapy.

8 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01066.X

Predictive value of venom-specific IgE, IgG and IgG subclass antibodies in patients on immunotherapy with honey bee venom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01066.X

Evaluation of decline in serum venom-specific IgE as a criterion for stopping venom immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01066.X

Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01066.X

Role of interleukin 10 in specific immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01066.X

Modulation of T-cell response to phospholipase A2 and phospholipase A2-derived peptides by conventional bee venom immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01066.X

Determination of T-cell subpopulations and intracellular cytokine production (interleukin-2, interleukin-4, and interferon-gamma) by cord blood T-lymphocytes of neonates from atopic and non-atopic parents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01066.X

Flow cytometric detection of type 1 (IL-2, IFN-gamma) and type 2 (IL-4, IL-5) cytokines in T-helper and T-suppressor/cytotoxic cells in rheumatoid arthritis, allergic asthma and atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01066.X

Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01066.X

Bee venom phospholipase A2-specific T cell clones from human allergic and non-allergic individuals: cytokine patterns change in response to the antigen concentration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01066.X

Interleukin 4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01066.X

Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01066.X

Immunity to intracellular microbial pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01066.X

Modulation of interferon-gamma receptor during human T lymphocyte alloactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01066.X

IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01066.X

Regulation of IgE and IgG4 responses by allergen specific T-cell clones to bee venom phospholipase A2 in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01066.X

Venom immunotherapy: when is it reasonable to stop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01066.X

Evolution of sensitivity to Hymenoptera venom in 200 allergic patients followed for up to 3 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01066.X

In-hospital sting challenge in insect venom-allergic patients after stopping venom immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01066.X

Discontinuing venom immunotherapy: outcome after five years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01066.X

Evolution of lymphocyte transformation to wasp venom antigen during immunotherapy for wasp venom anaphylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01066.X

Lymphocyte Cytotoxicity in vitro: Activation and Release of a Cytotoxic Factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01066.X

Immune interferon release when a cloned cytotoxic T-cell line meets its correct influenza-infected target cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01066.X

10.1046/J.1365-2222.2001.01066.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11422133%20AND%20SRC:MED&resulttype=core&format=json

release_rljbwan345htvpnqlprpwydkz4

8 November 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rljbwan345htvpnqlprpwydkz4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference